The U.S. Preventive Services Task Force (USPSTF) says that women should use hormone replacement therapy (HRT) to treat menopause symptoms only for short periods of time. The task force published the results of the study in the most recent edition of the Annals of Internal Medicine (October 24).
USPSTF surveyed 51 previous studies published since 2002 to find that HRT, which combines estrogen and progestin, is linked with increased risk of stroke, blood clots, gallbladder disease, urinary incontinence, dementia and breast cancer.
"This recommendation applies only to postmenopausal women who are considering hormone therapy for the primary prevention of chronic medical conditions. This is not a recommendation about the use of hormone therapy to treat menopausal symptoms, such as hot flashes or vaginal dryness," the agency stated in its recommendation.
An October 9 Danish study that analyzed slightly younger women seemed to have been countered by the USPSTF's study.
For comments and feedback contact: editorial@rttnews.com
Health News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.